Immunotherapy Trials in the Urology Practices - Timothy Richardson

Tim Richardson and Alicia Morgans highlight the value of participating in clinical trials.  They discuss trials evaluating immunotherapies in advanced bladder cancer, including operationalizing the process for managing the potential toxicities associated with these therapies. They also discuss the ongoing trials in high-risk, non-muscle invasive bladder cancer and discuss the importance of effective patient education, as well as co-managing the patients with oncology partners.

Biographies:

Alicia Morgans, MD, MPH

Timothy A. Richardson, MD. is a urologist in Wichita, Kansas and is affiliated with multiple hospitals in the area, including Harry S. Truman Memorial Veterans Hospital and Kansas Medical Center. He received his medical degree from University of Kansas School of Medicine.
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe